Neuren Pharmaceuticals | NEU - Operating Expenses

Stock Price
11.40
Daily Change
-0.17 -1.47%
Monthly
-12.38%
Yearly
-7.32%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD25.23M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 43.82M 16.98M Mar/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Clinuvel Pharmaceuticals AUD 20.71M 2.35M Jun/2024
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Genetic Signatures AUD 17.52M 9.22M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
Medical Developments International AUD 21.61M 11.59M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Paradigm Biopharmaceuticals AUD 8.49M 2.13M Jun/2025
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Tectonic Therapeutic USD 21.89M 440K Sep/2025
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025
Viatris USD 3.86B 335.7M Dec/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025